Developer docs
API playgroundTry for free, no card

Search company profiles

AZmed

Full company profile

uuid0000red

Namestring
AZmed
Legal namestring
AZmed
Websiteurl
azmed.co
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI radiology software, medical imaging AI, fracture detection AI, radiology workflow automation, X-ray analysis software
Industry6 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
AI Radiology Software
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1AI Radiology Software Subscriptions
TypeSubscription Recurring
Description

AZmed generates revenue primarily through subscription licensing of its Rayvolve AI Suite to healthcare facilities. Healthcare organizations (hospitals, imaging centers, urgent care clinics) pay for access to AI modules that integrate into their existing PACS workflows. Pricing is quote-based and structured around the number of modules, facilities, and volume of X-rays processed. The model is recurring in nature as healthcare providers renew licenses annually.

azmed.co
2OEM/Embedded Licensing via Platform Partners
TypeLicensing Royalties
Description

AZmed embeds its AI Suite within Fujifilm Synapse PACS through the Fujifilm AI Orchestrator. Revenue is generated through licensing arrangements with Fujifilm as the OEM partner, which distributes AZmed's technology as a native feature of its enterprise imaging platform. This creates a channel revenue stream where AZmed's tools reach customers without a direct sales touch.

azmed.co
3Channel Distribution (Nexus-MD)
TypeSubscription Recurring
Description

AZmed's partnership with Nexus-MD for U.S. distribution follows a channel/reseller model where Nexus-MD promotes and distributes AZmed's FDA-cleared tools (AZtrauma and AZchest) through its network of healthcare providers in the United States. This extends AZmed's market reach in the U.S. without building a direct sales infrastructure.

azmed.co
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1All modules (AZtrauma, AZchest, AZmeasure, AZboneage) available as part of the Rayvolve AI Suite, with modular or bundled deployment options.
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing listed. Enterprise licensing is structured around module selection, facility count, and imaging volume. Contact-based quoting required.

azmed.co
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1Rayvolve AI Suite
Description

AI-powered radiology platform for medical imaging analysis including fracture detection, chest X-ray analysis, musculoskeletal measurements, and pediatric bone age estimation.

azmed.co
+6 more records
Core offering1 text field

AZmed develops and sells the Rayvolve AI Suite, a regulated AI radiology software platform that automatically analyzes X-ray images upon acquisition to detect fractures (AZtrauma), chest pathologies (AZchest), musculoskeletal measurements (AZmeasure), and pediatric bone age (AZboneage), delivering annotated DICOM secondary outputs into the radiologist's existing PACS worklist. It is sold primarily on annual subscription licenses to hospitals, emergency departments, urgent care clinics, outpatient imaging networks, and pediatric hospitals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • 83% turnaround time reduction with AZtrauma deployment
+14 more records
Product overview1 text field

AZmed offers two AI radiology platforms: the Rayvolve AI Suite (FDA-cleared and CE-marked) for X-ray analysis comprising four modules (AZtrauma for fracture/dislocation/effusion detection, AZchest for chest pathology, AZmeasure for orthopedic measurements, and AZboneage for pediatric skeletal maturity), and the Rayscan AI Suite (CE-marked) for CT imaging, beginning with AZnod for lung nodule detection. Both platforms integrate directly into PACS via DICOM standard, providing automatic worklist triage and annotated secondary outputs without requiring additional login or workflow changes.

Product and service7 records
1Rayvolve AI Suite
CategoryAI Radiology Software Platform
Description

Integrated AI radiology software platform for hospitals, emergency departments, urgent care, and imaging centers that automatically analyzes X-ray images on PACS acquisition and provides CAD support, triage, and measurements within the existing radiologist worklist.

2AZtrauma
CategoryAI X-ray Fracture Detection Module
Description

FDA-cleared and CE-marked AI module for fracture, dislocation, and joint effusion detection on X-rays for adult and pediatric patients (ages 2+), providing automatic worklist triage and CAD output inside PACS.

3AZchest
CategoryAI Chest X-ray Pathology Module
Description

AI module for automated detection and triage of major heart and lung diseases from chest X-rays, including lung nodule detection, pneumothorax, pleural effusion, consolidation, and cardiomegaly, with FDA clearance and CE marking.

4AZmeasure
CategoryAI Musculoskeletal Measurement Module
Description

CE-marked AI module for automated musculoskeletal measurements on X-rays, covering scoliosis (Cobb angle), hallux valgus, leg length discrepancies, hip dysplasia, and femoroacetabular impingement, with structured DICOM output eliminating inter-observer variability.

5AZboneage
CategoryAI Pediatric Bone Age Estimation Module
Description

CE-marked AI module that estimates pediatric skeletal maturity from hand radiographs using the Greulich and Pyle method, generating structured reports comparing bone age to chronological age within 60 seconds of acquisition.

6Rayscan AI Suite
CategoryAI CT Imaging Platform
Description

AI software platform for CT imaging analysis introduced as a strategic extension of the Rayvolve portfolio, starting with pulmonary nodule detection (AZnod) and built to expand into additional CT use cases.

7AZnod
CategoryAI CT Lung Nodule Detection Module
Description

CE-marked AI module that detects and characterizes pulmonary nodules on CT scans to support lung cancer screening and clinical assessment, delivered as the first product in the Rayscan suite.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-22
Description

Radin Health and AZmed announced an expanded strategic partnership aimed at improving radiology workflows. AZmed received its third FDA clearance for the Rayvolve AI Suite's AZtrauma module, with Radin Health's cloud-based platform integrating AZmed's AI modules including AZtrauma and AZchest. The partnership supports the clearance with clinical validation data and enables joint go-to-market in the US market.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-03-12
Description

AZmed partnered with Fujifilm to integrate its complete Rayvolve AI Suite into Fujifilm's Synapse PACS via the Fujifilm AI Orchestrator. AZ Sint-Blasius in Belgium is the first hospital to deploy the integrated solution. The partnership enables zero-friction AI activation — radiologists receive AI analysis automatically without additional logins or workflow changes. AZmed and Fujifilm plan to expand beyond X-ray analysis to include AZnod (CT lung nodule detection) from the Rayscan suite.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-18
Description

AZmed and Nexus-MD partnered to expand access to FDA-cleared AI radiology tools (AZtrauma and AZchest) across the U.S. healthcare market. Nexus-MD distributes AZmed's tools through its network of healthcare providers, supporting clinical decision-making and diagnostic workflow improvement.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SimonMed Imaging deployed AZtrauma across 150 outpatient imaging locations across the United States and presented operational outcomes at RSNA 2023. Data from over 330,000 live X-ray cases demonstrated fracture turnaround time reduction from 48 hours to 8.3 hours and fracture detection rate increase from 10.4% to 11.8% after 6 months.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AZ Sint-Blasius deployed AZtrauma in August 2023 and expanded to the full Rayvolve AI Suite after a successful six-month clinical evaluation. As the first hospital to implement AZmed's full suite integrated through Fujifilm Synapse PACS, AZ Sint-Blasius provides ongoing clinical validation and reference site support for the Fujifilm partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Gleamer is a French radiology AI startup with the closest direct overlap to AZmed—AI-powered X-ray analysis including fracture detection (BoneView), chest X-ray triage, and pediatric bone age assessment, integrated into PACS workflows. Both companies compete for the same European hospital and urgent care customers with similar AI-on-X-ray value propositions.

TypeDirect peer
Description

Annalise.ai builds comprehensive AI imaging models covering chest X-ray, CT, and musculoskeletal findings, competing directly with AZmed's Rayvolve and Rayscan suites. Both target enterprise radiology deployments via PACS integration and OEM partnerships and emphasize regulatory clearance breadth and multi-pathology coverage.

TypeDirect peer
Description

Qure.ai is a well-funded radiology AI company whose qXR product directly overlaps with AZmed's AZchest (chest X-ray pathology detection) and qER competes in head CT. Both companies pursue FDA/CE cleared AI tools targeting emergency and urgent care, with global emerging-market expansion strategies.

TypeDirect peer
Description

Lunit is a publicly listed Korean radiology AI company with Lunit INSIGHT CXR (chest X-ray) and Lunit INSIGHT MMG (mammography) directly overlapping with AZmed's AZchest chest pathology detection. Both compete for enterprise radiology contracts globally with FDA/CE cleared AI modules.

TypeDirect peer
Description

Aidoc is a leading AI radiology platform offering triage and detection algorithms across CT and X-ray modalities, integrated into PACS workflows via the Aidoc aiOS platform. While broader in modality than AZmed today, Aidoc represents a comparable AI-orchestration-and-detection vendor competing for the same hospital enterprise contracts.

TypeDirect peer
Description

RapidAI provides AI-driven imaging analysis primarily for stroke and vascular imaging, with PACS/workflow integration comparable to AZmed's Rayvolve suite. While AZmed is X-ray focused and RapidAI is CT/neurovascular focused, both target acute care hospital customers with similar OEM and channel-driven GTM motions.

TypeDirect peer
Description

Viz.ai is a leader in AI-powered clinical workflow and detection, with FDA-cleared modules for stroke (LVO) triage expanding into cardiology and trauma. While the modality focus differs (CT/angio vs. AZmed's X-ray focus), Viz.ai shares AZmed's enterprise field-sales and channel-driven GTM targeting acute care hospitals.

TypeBroad incumbent
Description

Philips is a global incumbent in medical imaging whose AI Radiology portfolio (including the Philips Radiology AI Suite integrated with their PACS) overlaps with AZmed's Rayvolve and Rayscan. Philips is both an integration partner for AZmed and a broader competitor offering an end-to-end imaging + AI + reporting stack.

TypeOthers
Description

Blackford Analysis (now part of Bayer AG) operates an AI platform that aggregates third-party radiology AI algorithms, including AZmed's Rayvolve suite, for distribution to hospitals. Blackford is both an integration partner and a channel competitor that could resell competing AI algorithms alongside AZmed's.

TypeEmerging player
Description

Imagen Technologies (now Imagen) develops FDA-cleared AI for MSK and fracture detection on X-rays with workflow integration similar to AZmed's AZtrauma. Both target outpatient imaging and urgent care customers with embedded PACS AI, representing meaningful direct overlap in the fracture detection niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AZmed

AI Radiology Softwareazmed.co

AZmed firmographics

Firmographics
Name
AZmed
Legal name
AZmed
Website
https://azmed.co
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

AZmed industry classification

Industry
Product category
AI Radiology Software
NAICS
Diagnostic Imaging Centers (621512)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • AI radiology software
  • Medical imaging AI
  • Fracture detection AI
  • Radiology workflow automation
  • X-ray analysis software

Where AZmed is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

AZmed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. AI Radiology Software Subscriptions: AZmed generates revenue primarily through subscription licensing of its Rayvolve AI Suite to healthcare facilities. Healthcare organizations (hospitals, imaging centers, urgent care clinics) pay for access to AI modules that integrate into their existing PACS workflows. Pricing is quote-based and structured around the number of modules, facilities, and volume of X-rays processed. The model is recurring in nature as healthcare providers renew licenses annually.
  2. OEM/Embedded Licensing via Platform Partners: AZmed embeds its AI Suite within Fujifilm Synapse PACS through the Fujifilm AI Orchestrator. Revenue is generated through licensing arrangements with Fujifilm as the OEM partner, which distributes AZmed's technology as a native feature of its enterprise imaging platform. This creates a channel revenue stream where AZmed's tools reach customers without a direct sales touch.
  3. Channel Distribution (Nexus-MD): AZmed's partnership with Nexus-MD for U.S. distribution follows a channel/reseller model where Nexus-MD promotes and distributes AZmed's FDA-cleared tools (AZtrauma and AZchest) through its network of healthcare providers in the United States. This extends AZmed's market reach in the U.S. without building a direct sales infrastructure.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAll modules (AZtrauma, AZchest, AZmeasure, AZboneage) available as part of the Rayvolve AI Suite, with modular or bundled deployment options.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

AZmed product offering

Product offering

Core offering

AZmed develops and sells the Rayvolve AI Suite, a regulated AI radiology software platform that automatically analyzes X-ray images upon acquisition to detect fractures (AZtrauma), chest pathologies (AZchest), musculoskeletal measurements (AZmeasure), and pediatric bone age (AZboneage), delivering annotated DICOM secondary outputs into the radiologist's existing PACS worklist. It is sold primarily on annual subscription licenses to hospitals, emergency departments, urgent care clinics, outpatient imaging networks, and pediatric hospitals.

Product overview

AZmed offers two AI radiology platforms: the Rayvolve AI Suite (FDA-cleared and CE-marked) for X-ray analysis comprising four modules (AZtrauma for fracture/dislocation/effusion detection, AZchest for chest pathology, AZmeasure for orthopedic measurements, and AZboneage for pediatric skeletal maturity), and the Rayscan AI Suite (CE-marked) for CT imaging, beginning with AZnod for lung nodule detection. Both platforms integrate directly into PACS via DICOM standard, providing automatic worklist triage and annotated secondary outputs without requiring additional login or workflow changes.

Differentiator

Problem solved

Functional benefit

Brands

  • Rayvolve AI Suite: AI-powered radiology platform for medical imaging analysis including fracture detection, chest X-ray analysis, musculoskeletal measurements, and pediatric bone age estimation.
  • AZtrauma
  • AZchest
  • AZmeasure
  • AZboneage
  • Rayscan
  • AZnod

Products and services

  • Rayvolve AI Suite Integrated AI radiology software platform for hospitals, emergency departments, urgent care, and imaging centers that automatically analyzes X-ray images on PACS acquisition and provides CAD support, triage, and measurements within the existing radiologist worklist.
  • AZtrauma FDA-cleared and CE-marked AI module for fracture, dislocation, and joint effusion detection on X-rays for adult and pediatric patients (ages 2+), providing automatic worklist triage and CAD output inside PACS.
  • AZchest AI module for automated detection and triage of major heart and lung diseases from chest X-rays, including lung nodule detection, pneumothorax, pleural effusion, consolidation, and cardiomegaly, with FDA clearance and CE marking.
  • AZmeasure CE-marked AI module for automated musculoskeletal measurements on X-rays, covering scoliosis (Cobb angle), hallux valgus, leg length discrepancies, hip dysplasia, and femoroacetabular impingement, with structured DICOM output eliminating inter-observer variability.
  • AZboneage CE-marked AI module that estimates pediatric skeletal maturity from hand radiographs using the Greulich and Pyle method, generating structured reports comparing bone age to chronological age within 60 seconds of acquisition.
  • Rayscan AI Suite AI software platform for CT imaging analysis introduced as a strategic extension of the Rayvolve portfolio, starting with pulmonary nodule detection (AZnod) and built to expand into additional CT use cases.
  • AZnod CE-marked AI module that detects and characterizes pulmonary nodules on CT scans to support lung cancer screening and clinical assessment, delivered as the first product in the Rayscan suite.

Quantifiable outcome

  • 83% turnaround time reduction with AZtrauma deployment
  • +14 more outcomes

Companies that use AZmed

Customer profile

Named customers21 records

Segments5 records

Ideal customer profiles4 records

AZmed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature8 records

AZmed partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and flagship.

  • Radin HealthcoreStrategic or Co-development Partner · 22 May 2026Radin Health and AZmed announced an expanded strategic partnership aimed at improving radiology workflows. AZmed received its third FDA clearance for the Rayvolve AI Suite's AZtrauma module, with Radin Health's cloud-based platform integrating AZmed's AI modules including AZtrauma and AZchest. The partnership supports the clearance with clinical validation data and enables joint go-to-market in the US market.
  • FujifilmflagshipOEM/ Whitelabel/ Licensing Partner · 12 March 2026AZmed partnered with Fujifilm to integrate its complete Rayvolve AI Suite into Fujifilm's Synapse PACS via the Fujifilm AI Orchestrator. AZ Sint-Blasius in Belgium is the first hospital to deploy the integrated solution. The partnership enables zero-friction AI activation — radiologists receive AI analysis automatically without additional logins or workflow changes. AZmed and Fujifilm plan to expand beyond X-ray analysis to include AZnod (CT lung nodule detection) from the Rayscan suite.
  • Nexus-MDcoreChannel Partner/ Reseller/ Distributor · 18 April 2025AZmed and Nexus-MD partnered to expand access to FDA-cleared AI radiology tools (AZtrauma and AZchest) across the U.S. healthcare market. Nexus-MD distributes AZmed's tools through its network of healthcare providers, supporting clinical decision-making and diagnostic workflow improvement.
  • SimonMed ImagingcoreStrategic or Co-development PartnerSimonMed Imaging deployed AZtrauma across 150 outpatient imaging locations across the United States and presented operational outcomes at RSNA 2023. Data from over 330,000 live X-ray cases demonstrated fracture turnaround time reduction from 48 hours to 8.3 hours and fracture detection rate increase from 10.4% to 11.8% after 6 months.
  • AZ Sint-Blasius (Belgium)coreStrategic or Co-development PartnerAZ Sint-Blasius deployed AZtrauma in August 2023 and expanded to the full Rayvolve AI Suite after a successful six-month clinical evaluation. As the first hospital to implement AZmed's full suite integrated through Fujifilm Synapse PACS, AZ Sint-Blasius provides ongoing clinical validation and reference site support for the Fujifilm partnership.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

AZmed competitors and assessment

Company assessment

Direct peers

  • Gleamer: Gleamer is a French radiology AI startup with the closest direct overlap to AZmed—AI-powered X-ray analysis including fracture detection (BoneView), chest X-ray triage, and pediatric bone age assessment, integrated into PACS workflows. Both companies compete for the same European hospital and urgent care customers with similar AI-on-X-ray value propositions.
  • Annalise.ai: Annalise.ai builds comprehensive AI imaging models covering chest X-ray, CT, and musculoskeletal findings, competing directly with AZmed's Rayvolve and Rayscan suites. Both target enterprise radiology deployments via PACS integration and OEM partnerships and emphasize regulatory clearance breadth and multi-pathology coverage.
  • Qure.ai: Qure.ai is a well-funded radiology AI company whose qXR product directly overlaps with AZmed's AZchest (chest X-ray pathology detection) and qER competes in head CT. Both companies pursue FDA/CE cleared AI tools targeting emergency and urgent care, with global emerging-market expansion strategies.
  • Lunit: Lunit is a publicly listed Korean radiology AI company with Lunit INSIGHT CXR (chest X-ray) and Lunit INSIGHT MMG (mammography) directly overlapping with AZmed's AZchest chest pathology detection. Both compete for enterprise radiology contracts globally with FDA/CE cleared AI modules.
  • Aidoc: Aidoc is a leading AI radiology platform offering triage and detection algorithms across CT and X-ray modalities, integrated into PACS workflows via the Aidoc aiOS platform. While broader in modality than AZmed today, Aidoc represents a comparable AI-orchestration-and-detection vendor competing for the same hospital enterprise contracts.
  • RapidAI: RapidAI provides AI-driven imaging analysis primarily for stroke and vascular imaging, with PACS/workflow integration comparable to AZmed's Rayvolve suite. While AZmed is X-ray focused and RapidAI is CT/neurovascular focused, both target acute care hospital customers with similar OEM and channel-driven GTM motions.
  • Viz.ai: Viz.ai is a leader in AI-powered clinical workflow and detection, with FDA-cleared modules for stroke (LVO) triage expanding into cardiology and trauma. While the modality focus differs (CT/angio vs. AZmed's X-ray focus), Viz.ai shares AZmed's enterprise field-sales and channel-driven GTM targeting acute care hospitals.

Broad incumbents

  • Philips (AI Radiology): Philips is a global incumbent in medical imaging whose AI Radiology portfolio (including the Philips Radiology AI Suite integrated with their PACS) overlaps with AZmed's Rayvolve and Rayscan. Philips is both an integration partner for AZmed and a broader competitor offering an end-to-end imaging + AI + reporting stack.

Others

  • Blackford Analysis (Bayer): Blackford Analysis (now part of Bayer AG) operates an AI platform that aggregates third-party radiology AI algorithms, including AZmed's Rayvolve suite, for distribution to hospitals. Blackford is both an integration partner and a channel competitor that could resell competing AI algorithms alongside AZmed's.

Emerging players

  • Imagen Technologies: Imagen Technologies (now Imagen) develops FDA-cleared AI for MSK and fracture detection on X-rays with workflow integration similar to AZmed's AZtrauma. Both target outpatient imaging and urgent care customers with embedded PACS AI, representing meaningful direct overlap in the fracture detection niche.

Market position

Strengths5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

AZmed social profiles

Digital presence

AZmed compliance and trust

Trust signal

Compliance3 records

AZmed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AZmed leadership team

Management profile

Number of profiles

Profiles3 records

AZmed funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AZmed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AZmed

What does AZmed do?

AZmed develops and sells the Rayvolve AI Suite, a regulated AI radiology software platform that automatically analyzes X-ray images upon acquisition to detect fractures (AZtrauma), chest pathologies (AZchest), musculoskeletal measurements (AZmeasure), and pediatric bone age (AZboneage), delivering annotated DICOM secondary outputs into the radiologist's existing PACS worklist. It is sold primarily on annual subscription licenses to hospitals, emergency departments, urgent care clinics, outpatient imaging networks, and pediatric hospitals.

Is AZmed a public or private company?

AZmed is a private company. It is classified as venture growth investor backed and is currently operating.

When was AZmed founded?

AZmed was founded in 2018. It employs 101 to 250 people.

Where is AZmed based?

AZmed is headquartered in Paris, France, in the Europe region.

How does AZmed make money?

Three revenue lines are on record. AI Radiology Software Subscriptions are the primary driver. The others are OEM/Embedded Licensing via Platform Partners and channel Distribution (Nexus-MD).

Who are AZmed's main competitors?

Direct peers on record are Gleamer, Annalise.ai, Qure.ai, Lunit, Aidoc, RapidAI and Viz.ai. Philips (AI Radiology) is listed as a broad incumbent. Blackford Analysis (Bayer) is listed as an others. Imagen Technologies is listed as an emerging player.

Does AZmed have an API?

No public API is recorded for AZmed.

What industry is AZmed in?

AZmed's product category is AI Radiology Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 621512 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialUSARAD, A Nanox Company, Expands Collaboration With Azmed To Integrate FDA-Cleared X-Ray AI Into Its Teleradiology WorkflowsUSARAD Holdings is expanding its collaboration with AZmed to integrate AZmed's FDA-cleared X-ray AI suite into its teleradiology workflows via Nanox Marketplace. The suite covers eight findings across musculoskeletal and chest X-rays, including AZtrauma and AZchest, and will enable automated study routing and DICOM transmission.FinancialContent Business PageUSARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology WorkflowsUSARAD Holdings is expanding its collaboration with AZmed to integrate AZmed's FDA-cleared X-ray AI suite into its teleradiology workflows via Nanox Marketplace. The suite covers eight findings across musculoskeletal and chest X-rays, including fracture detection and pneumothorax. The integration aims to help radiologists prioritize and read studies more efficiently.YahooUSARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology WorkflowsUSARAD Holdings is expanding its collaboration with AZmed to integrate AZmed's FDA-cleared X-ray AI suite into its teleradiology workflows via Nanox Marketplace. The suite covers eight findings across musculoskeletal and chest X-rays, including fracture detection and pneumothorax. The integration aims to help radiologists prioritize and read studies more efficiently.Stock TitanNanox Expands AZmed FDA-Cleared X-ray AI IntegrationNanox's USARAD is expanding its collaboration with AZmed to integrate AZmed's FDA-cleared X-ray AI suite into its radiology workflows via Nanox Marketplace. The suite covers eight findings across musculoskeletal and chest X-rays, including fracture detection and pneumothorax, and will be delivered through automated DICOM transmission.Digital Health NewsKrsnaa Diagnostics Collaborates with Global Radiology AI Innovator AZmedKrsnaa Diagnostics partnered with France-based AZmed to evaluate its Rayvolve AI suite for radiology operations, focusing on fracture detection and triage using X-rays. The initiative aims to assess AI-assisted image analysis for reporting workflows and operational efficiency. Krsnaa processes over five million X-rays annually across 2,000 centres.Medical BuyerKrsnaa Diagnostics, AZmed partner to evaluate AI solutions for radiologyKrsnaa Diagnostics and AZmed are collaborating to evaluate AI solutions for radiology, deploying AZmed's Rayvolve suite to improve fracture detection and triage. Krsnaa processes over 5 million X-rays annually across 19 states, while AZmed's technology has analyzed 15 million images globally. The partnership aims to enhance operational efficiency and support business expansion.Zee BusinessKrsnaa Diagnostics announces strategic AI collaboration with AZmed; shares fallKrsnaa Diagnostics announced a strategic collaboration with AZmed to evaluate AI-assisted radiology solutions, including AZtrauma for fracture detection. The company processes over 5 million X-rays annually, and shares fell 1.18% to Rs 508.90 on NSE.ScanXKrsnaa Diagnostics signs AI collaboration deal with AZmedKrsnaa Diagnostics signed a collaboration with AZmed to evaluate AI for fracture detection, targeting efficiency gains across its 5 million annual X-rays. AZmed's Rayvolve suite holds FDA and CE clearances, and the partnership aims to unlock operating leverage through scalable AI integration.Imaging Technology NewsRadin Health, AZmed Team Up to Enhance Radiology WorkflowRadin Health and AZmed announced an expanded strategic partnership aimed at improving radiology workflows, with AZmed receiving its third FDA clearance for the Rayvolve AI Suite's AZtrauma module. The new clearance broadens the application's scope to include joint effusions and dislocations on X-rays, covering all three pathologies across adult and pediatric populations.PR NewswireRADIN Health and AZmed Elevate Radiology Workflow with AZtrauma's Expanded FDA-Cleared AI CapabilitiesAZmed has received its third FDA clearance for the Rayvolve AI Suite's AZtrauma module, expanding its scope to detect fractures, joint effusions, and dislocations across adult and pediatric populations on X-rays, making it the only FDA-cleared AI solution in the United States covering all three pathologies. The expanded clearance strengthens the existing strategic partnership between AZmed and RADIN Health, whose cloud-based platform integrates the AI modules to provide automated analysis and triage. The milestone follows the Cohen et al. (2026) validation study using 258,373 X-rays from 100 clinical centers across 26 countries, and the technology reportedly boosts radiology reporting speed by up to 70%.